NovaBridge Biosciences annual net debt
2019
2020
2021
2022
2023
2024
2025
NovaBridge Biosciences Net Debt Growth & History (NBP)
NovaBridge Biosciences's net debt was −$207.6M for fiscal 2025.
View full NovaBridge Biosciences company overviewNovaBridge Biosciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$207.6M | −$143.2M | — |
| 2024 | 2024-12-31 | −$64.4M | $216.6M | — |
| 2023 | 2023-12-31 | −$280.9M | $51.1M | — |
| 2022 | 2022-12-31 | −$332.1M | $203.2M | — |
| 2021 | 2021-12-31 | −$535.3M | $191.9M | — |
| 2020 | 2020-12-31 | −$727.2M | −$573.1M | — |
| 2019 | 2019-12-31 | −$154.2M | — | — |
NovaBridge Biosciences quarterly net debt
Q4.19
Q3.20
Q4.20
Q4.21
Q2.22
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$186.2M | −$24.3M | — |
| Q4 2025 | 2025-12-31 | −$207.6M | −$143.2M | — |
| Q3 2025 | 2025-09-30 | −$224.8M | — | — |
| Q2 2025 | 2025-06-30 | −$161.9M | — | — |
| Q1 2025 | 2025-03-31 | −$49.9M | — | — |
| Q4 2024 | 2024-12-31 | −$64.4M | $216.6M | — |
| Q4 2023 | 2023-12-31 | −$280.9M | $51.1M | — |
| Q4 2022 | 2022-12-31 | −$332.1M | $203.2M | — |
| Q2 2022 | 2022-06-30 | −$538.5M | — | — |
| Q4 2021 | 2021-12-31 | −$535.3M | $191.9M | — |
| Q4 2020 | 2020-12-31 | −$727.2M | −$573.1M | — |
| Q3 2020 | 2020-09-30 | −$434.0M | — | — |
| Q4 2019 | 2019-12-31 | −$154.2M | — | — |
NovaBridge Biosciences net debt trends
Over the last five fiscal years, NovaBridge Biosciences's net debt increased from −$727.2M to −$207.6M, a change of $519.7M. The latest reported quarter, Q2 2026, shows −$186.2M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NovaBridge Biosciences source filings ↗